Pevion Biotech Ltd.
Records under this name other than the patents Pevion Biotech Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,852,604 | Multiepitope Vaccine for Her2/Neu-Associated Cancers Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 9,610,334 | Truncated secretory aspartyl proteinase 2 Formerly held Lapsed on the fee record Ended Apr 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | From the USPTO record |
| US 7,198,791 | Compositions and methods for the generation of protective immune responses against malaria Formerly held Term ended Term ended Apr 25, 2023 · From the USPTO record | Term ended | Term ended Apr 25, 2023 | From the USPTO record |
| US 8,715,698 | Truncated secretory aspartyl proteinase 2 Formerly held Lapsed on the fee record Ended May 6, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2022 | From the USPTO record |
| US 8,496,962 | Trans-adjuvant system Lapsed on the fee record Ended Jul 30, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 30, 2021 | From the USPTO record |
| US 8,372,963 | RSV F-protein and its use Lapsed on the fee record Ended Feb 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2021 | From the USPTO record |
| US 8,367,077 | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof Lapsed on the fee record Ended Feb 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2021 | From the USPTO record |
| US 7,378,495 | PTH-rP related peptide cancer therapeutics Lapsed on the fee record Ended May 27, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2020 | From the USPTO record |
| US 7,329,807 | High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them Lapsed on the fee record Ended Feb 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2020 | From the USPTO record |
| US 7,569,541 | Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines Formerly held Lapsed on the fee record Ended Aug 4, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 4, 2017 | From the USPTO record |